All Relations between dopaminergic and dopamine

Publication Sentence Publish Date Extraction Date Species
J Feigenbaum, J Yanai, H L Klawans, R Chatterto. The combined effect of quipazine and haloperidol on plasma prolactin release. The International journal of neuroscience. vol 18. issue 1-2. 1983-06-10. PMID:6840980. the possible dopaminergic properties of the central serotonergic agonist quipazine was examined using plasma prolactin release as a model to determine whether quipazine exerts an agonist effect on only serotonin receptors or on dopamine receptors as well. 1983-06-10 2023-08-12 Not clear
J A Jackson, J Jankovic, J For. Progressive supranuclear palsy: clinical features and response to treatment in 16 patients. Annals of neurology. vol 13. issue 3. 1983-06-10. PMID:6847139. alternatively, dopamine agonists (bromocriptine and pergolide) caused improvement in 9 of 14 patient trials despite the fact that all but 1 of these patients had previously failed to respond to presynaptic dopaminergic drugs. 1983-06-10 2023-08-12 Not clear
P D Gluckman, S Leisti, S L Kaplan, M M Grumbac. Hormone ontogeny in the ovine fetus. XV. Studies of adenohypophysial hormones after fetal pituitary stalk section: evidence for an extrahypothalamic dopaminergic influence on fetal prolactin secretion. Endocrinology. vol 112. issue 5. 1983-05-27. PMID:6403331. the administration of a dopamine antagonist, haloperidol, to the ovine fetus in late gestation elevates plasma concentrations of prl, suggesting tonic dopaminergic inhibition of fetal prl secretion. 1983-05-27 2023-08-12 Not clear
P D Gluckman, S Leisti, S L Kaplan, M M Grumbac. Hormone ontogeny in the ovine fetus. XV. Studies of adenohypophysial hormones after fetal pituitary stalk section: evidence for an extrahypothalamic dopaminergic influence on fetal prolactin secretion. Endocrinology. vol 112. issue 5. 1983-05-27. PMID:6403331. these data suggest that there is persistent dopaminergic inhibition of prl secretion in the fetus after complete stalk section, and that the source of this dopamine is extrahypothalamic. 1983-05-27 2023-08-12 Not clear
J J Pehrson, W L Jaffee, J L Vaitukaiti. Effect of dopamine on gonadotropin-releasing hormone-induced gonadotropin secretion in postmenopausal women. The Journal of clinical endocrinology and metabolism. vol 56. issue 5. 1983-05-27. PMID:6403569. five healthy women who had previously undergone spontaneous menopause and had not received exogenous estrogens were studied with infusions of synthetic gnrh and dopamine to ascertain the site of dopaminergic modulation of pituitary gonadotropin secretion. 1983-05-27 2023-08-12 Not clear
C N Karson, J E Kleinman, K F Berman, B H Phelps, C D Wise, L E DeLisi, D V Jest. An inverse correlation between spontaneous eye-blink rate and platelet monoamine oxidase activity. The British journal of psychiatry : the journal of mental science. vol 142. 1983-05-27. PMID:6831128. insofar as this relationship is mediated by dopamine, it suggests that dopaminergic relations are more readily demonstrated in schizophrenic subjects than normals. 1983-05-27 2023-08-12 human
S M Foord, J R Peters, C Dieguez, M F Scanlon, R Hal. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin. Endocrinology. vol 112. issue 5. 1983-05-27. PMID:6832061. dopamine (da) and the dopaminergic agonists bromocriptine and apomorphine inhibit the secretion of tsh as well as that of prl by rat anterior pituitary (ap) cells in monolayer culture. 1983-05-27 2023-08-12 rat
E Roti, G Robuschi, R Emanuele, L d'Amato, A Gnudi, M Fatone, L Benassi, M S Foscolo, C Gualerzi, L E Braverma. Failure of metoclopramide to affect thyrotropin concentration in the term human fetus. The Journal of clinical endocrinology and metabolism. vol 56. issue 5. 1983-05-27. PMID:6833467. thus, the dopaminergic inhibitory effect on anterior pituitary tsh secretion may not be an important factor in tsh regulation during pregnancy or in the fetus, or the dose of met employed may be unable to overcome the dopamine inhibitory effect. 1983-05-27 2023-08-12 human
J Ishiko, C Inagaki, S Takaor. Inhibitory effects of brotizolam, a new thienodiazepine, on limbic forebrain and neostriatal dopaminergic systems in vivo and in vitro. Neuropharmacology. vol 22. issue 2. 1983-05-27. PMID:6835488. these data suggest that brotizolam inhibits the release of dopamine in the limbic forebrain and neostriatal systems probably through mechanisms including a facilitation of gabaergic action on dopaminergic nerve terminals. 1983-05-27 2023-08-12 Not clear
H Azuma, K Iwai, K Sato, M Kikuta, H J Liu, N Oshin. [Suppressive effects of lisuride on the synthesis, release and metabolism of dopamine in rat brain]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica. vol 80. issue 5. 1983-05-05. PMID:6131854. effects of lisuride, a central dopaminergic agonist of the ergot type, on the biosynthesis, release and metabolism of dopamine at the dopaminergic nerve terminals of the rat brain were studied under several experimental conditions. 1983-05-05 2023-08-12 rat
P M Groves, J C Linde. Dendro-dendritic synapses in substantia nigra: descriptions based on analysis of serial sections. Experimental brain research. vol 49. issue 2. 1983-05-05. PMID:6832258. release of dopamine from dopaminergic dendrites and their role in the control of neuronal activity in substantial nigra are discussed. 1983-05-05 2023-08-12 human
G P Mereu, C Pacitti, A Argiola. Effect of (-)-cathinone, a khat leaf constituent, on dopaminergic firing and dopamine metabolism in the rat brain. Life sciences. vol 32. issue 12. 1983-05-05. PMID:6834994. effect of (-)-cathinone, a khat leaf constituent, on dopaminergic firing and dopamine metabolism in the rat brain. 1983-05-05 2023-08-12 rat
A Sasaki, K Hanew, S Sato, K Yoshinag. Evidence for endogenous dopaminergic regulation of thyrotropin (TSH) secretion in man. The Tohoku journal of experimental medicine. vol 139. issue 1. 1983-05-05. PMID:6836556. these results suggest that dopamine exerts physiologically tonic inhibition on tsh secretion and the dopaminergic tone on tsh secretion is higher in female than in male. 1983-05-05 2023-08-12 human
M F Chesselet, A Cheramy, T D Reisine, C Lubetzki, J Glowinski, M C Fournie-Zaluski, B Roque. Effects of various opiates including specific delta and mu agonists on dopamine release from nigrostriatal dopaminergic neurons in vitro in the rat and in vivo in the cat. Life sciences. vol 31. issue 20-21. 1983-04-21. PMID:6298522. effects of various opiates including specific delta and mu agonists on dopamine release from nigrostriatal dopaminergic neurons in vitro in the rat and in vivo in the cat. 1983-04-21 2023-08-12 rat
B Scatto. Further evidence for the involvement of D2, but not D1 dopamine receptors in dopaminergic control of striatal cholinergic transmission. Life sciences. vol 31. issue 25. 1983-04-21. PMID:6298532. further evidence for the involvement of d2, but not d1 dopamine receptors in dopaminergic control of striatal cholinergic transmission. 1983-04-21 2023-08-12 Not clear
R D Schwarz, N J Uretsky, J R Bianchin. Prostaglandin inhibition of apomorphine-induced circling in mice. Pharmacology, biochemistry, and behavior. vol 17. issue 6. 1983-04-21. PMID:6819586. these results are the first report suggesting that within dopamine (da)-mediated pathways pgs act at sites postsynaptic to the dopaminergic synapse. 1983-04-21 2023-08-12 mouse
J Arnt, A V Christensen, J Hyttel, J J Larsen, O Svendse. Effects of putative dopamine autoreceptor agonists in pharmacological models related to dopaminergic and neuroleptic activity. European journal of pharmacology. vol 86. issue 2. 1983-04-15. PMID:6130958. effects of putative dopamine autoreceptor agonists in pharmacological models related to dopaminergic and neuroleptic activity. 1983-04-15 2023-08-12 Not clear
M F Chesselet, A Chéramy, T D Reisine, C Lubetzki, M Desban, J Glowinsk. Local and distal effects induced by unilateral striatal application of opiates in the absence or in the presence of naloxone on the release of dopamine in both caudate nuclei and substantiae nigrae of the cat. Brain research. vol 258. issue 2. 1983-04-15. PMID:6824913. halothane-anesthetized cats implanted with push-pull cannulae in both caudate nuclei (cn) and substantiae nigrae (sn) were used to study the effects of naloxone and various opiates when applied into the left cn on the release of newly synthetized tritiated dopamine (da) from nerve terminals and dendrites of the two nigro-striatal dopaminergic pathways. 1983-04-15 2023-08-12 cat
I S Login, M J Cronin, C T Harcus, R M MacLeo. Neuroendocrine evidence that tetrabenazine is a dopamine antagonist. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.). vol 172. issue 2. 1983-04-15. PMID:6828467. the unusual ability of tetrabenazine both to antagonize dopamine and to block presynaptic dopamine storage may provide a new tool for understanding the physiology of dopaminergic systems. 1983-04-15 2023-08-12 rat
T J McCown, R A Mueller, G R Brees. Effects of anesthetics and electrical stimulation on nigrostriatal dopaminergic neurons. The Journal of pharmacology and experimental therapeutics. vol 224. issue 3. 1983-04-07. PMID:6827473. these data reveal an interaction between many anesthetics and physical disruption of dopaminergic neurons, as well as provide an in vivo model of stimulus-dependent dopamine release. 1983-04-07 2023-08-12 Not clear